Integrin Receptor Antagonists

Integrin Receptor Antagonist

Colitis, Ulcerative

Crohn Disease

Enteritis

<section class="Section" data-sectioncode="34089-3"><a name="S11"></a><a name="section-9"></a><p></p><h1>11 DESCRIPTION</h1><p class="First">Vedolizumab, an integrin receptor antagonist, is a humanized IgG<span class="Sub">1 </span>monoclonal antibody produced in Chinese hamster ovary cells that binds to the human α4β7 integrin. ENTYVIO has an approximate molecular weight of 147 kilodaltons.</p><div class="Section" data-sectioncode="42229-5"><a name="section-9.1"></a><p></p><p class="First"><span class="Italics Underline">Intravenous ENTYVIO</span></p><p>ENTYVIO (vedolizumab) for injection is supplied as a sterile, white to off-white, preservative-free, lyophilized cake for intravenous infusion. After reconstitution with 4.8 mL Sterile Water for Injection, USP, 0.9% Sodium Chloride Injection, USP, or Lactated Ringer's Injection, USP, the resulting concentration is 60 mg/mL with a deliverable volume of 5 mL (300 mg) and the resulting pH is approximately 6.3.</p><p>Each single-dose vial contains 300 mg vedolizumab, arginine hydrochloride (131.7 mg), histidine (23 mg), histidine monohydrochloride (21.4 mg), polysorbate 80 (3 mg), and sucrose (500 mg).</p></div><div class="Section" data-sectioncode="42229-5"><a name="section-9.2"></a><p></p><p class="First"><span class="Italics Underline">Subcutaneous ENTYVIO</span></p><p>ENTYVIO (vedolizumab) injection is supplied as a sterile, clear to moderately opalescent, colorless to slightly yellow, preservative-free solution for subcutaneous administration.</p><p>Each single-dose prefilled syringe or single-dose prefilled pen (ENTYVIO PEN) contains 108 mg vedolizumab, arginine hydrochloride (17.77 mg), citric acid monohydrate (0.18 mg), histidine (3.86 mg), histidine monohydrochloride (1.86 mg), polysorbate 80 (1.35 mg), sodium citrate dihydrate (4.71 mg) and Sterile Water for Injection, USP, at a pH of 6.5.</p></div></section>

Entyvio

vedolizumab

vedolizumab 300 MG Injection

vedolizumab 300 MG Injection [Entyvio]

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe [Entyvio]

0.68 ML vedolizumab 159 MG/ML Auto-Injector

0.68 ML vedolizumab 159 MG/ML Auto-Injector [Entyvio]

Dana Farber Cancer Institute Pharmacy

Adcetris

Afinitor

Aliqopa

Alunbrig

Aranesp

Avastin

Beleodaq

Blincyto

Bosulif

Calquence

Cometriq

Cotellic

Darzalex

Doxil

Empliciti

Erleada

Erivedge

Farydak

Folotyn

Gilotrif

Halavan

Herceptin

Ibrance

Idhifa

Imbruvica

Imfinzi

Inlyta

Istodax

Ixempra

Jakafi

Kadcyla

Keytruda

Lenvima

Lonsurf

Lynparza

Matalune

Mekinist

Nerlynx

Nexavar

Nplate

Odomzo

Opdivo

Oncaspar

Perjeta

Promacta

Revlimid

Rituxan

Rubraca

Soliris

Somatuline

Stivarga

Sutent

Tafinlar

Tagrisso

Tarceva

Targretin

Tasigna

Tecentriq

Temodar

Treanda

Tykerb

Venclexta

Vidaza

Votrient

Xalkori

Xtandi

Yervoy

Yondelis

Zaltrap

Zejula

Zelboraf

Zydelig

Zykadia

Entyvio | Dana Farber Cancer Institute Pharmacy

Does Dana Farber Cancer Institute Pharmacy offer services for Entyvio patients?

What conditions does Dana Farber Cancer Institute Pharmacy support?

How does Dana Farber Cancer Institute Pharmacy help with insurance?